Literature DB >> 23670800

Quantitative expression of human drug transporter proteins in lung tissues: analysis of regional, gender, and interindividual differences by liquid chromatography-tandem mass spectrometry.

Atsushi Sakamoto1, Takehisa Matsumaru, Norio Yamamura, Yasuo Uchida, Masanori Tachikawa, Sumio Ohtsuki, Tetsuya Terasaki.   

Abstract

The purpose of the present study was to clarify the expression levels of transporter proteins in human lung tissue and to analyze regional and interindividual differences in primary cultured epithelial cells. Organic cation/carnitine tranporter 1 (OCTN1) protein expression was highest (2.08 ± 1.19 fmol/μg protein) in human lung tissue, followed by multidrug resistance-associated protein 1 (MRP1) and breast cancer resistance protein expression (1.41 ± 0.41, 1.30 ± 1.29 fmol/μg protein, respectively). Interestingly, the same expression levels of OATP2B1 protein were demonstrated among the epithelial cells derived from all pulmonary regions for the first time. These results suggest that OCTN1 may be the best target transporter protein for pulmonary disease drug design, and OATP2B1 may be an alternative target. MRP1 protein expression was also high and mainly localized in bronchial and alveolar regions. Regarding interindividual differences, the MRP1 protein showed a significant 18-fold maximal difference in the bronchial region among five donors. Sixteen of the 18 transporters showed higher expression in female lungs than in male lungs, especially MRP8 showed a 7.32-fold maximal difference. In conclusion, the protein expression profiles of pulmonary drug transporters and regional, gender, and interindividual differences were clarified. These findings may provide significant insights for pulmonary disease drug design and indicate that administration by inhalation may be viable.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Analytical biochemistry; Drug transport; LC-MS; MRP1; Membrane transporter; OATP2B1; OCTN1; Pulmonary drug delivery; mass spectrometry; targeted proteomics

Mesh:

Substances:

Year:  2013        PMID: 23670800     DOI: 10.1002/jps.23606

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  23 in total

Review 1.  Mass spectrometry-based targeted proteomics as a tool to elucidate the expression and function of intestinal drug transporters.

Authors:  Stefan Oswald; Christian Gröer; Marek Drozdzik; Werner Siegmund
Journal:  AAPS J       Date:  2013-08-28       Impact factor: 4.009

2.  Expression and Activity of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Distal Lung Epithelial Cells In Vitro.

Authors:  Sabrina Nickel; Mohammed Ali Selo; Juliane Fallack; Caoimhe G Clerkin; Hanno Huwer; Nicole Schneider-Daum; Claus-Michael Lehr; Carsten Ehrhardt
Journal:  Pharm Res       Date:  2017-05-03       Impact factor: 4.200

3.  Inhalation Biopharmaceutics: Progress Towards Comprehending the Fate of Inhaled Medicines.

Authors:  Carsten Ehrhardt
Journal:  Pharm Res       Date:  2017-11-16       Impact factor: 4.200

Review 4.  Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.

Authors:  Kyunghee Yang; Cen Guo; Jeffrey L Woodhead; Robert L St Claire; Paul B Watkins; Scott Q Siler; Brett A Howell; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2016-02       Impact factor: 3.534

5.  Predicting Regional Respiratory Tissue and Systemic Concentrations of Orally Inhaled Drugs through a Novel PBPK Model.

Authors:  Mayur K Ladumor; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2022-03-04       Impact factor: 3.579

Review 6.  Small Airway Susceptibility to Chemical and Particle Injury.

Authors:  Leonie Francina Hendrina Fransen; Martin Oliver Leonard
Journal:  Respiration       Date:  2021-10-14       Impact factor: 3.966

7.  Celecoxib enhances sensitivity to chemotherapy drugs of T-cell lymphoma.

Authors:  Ming Ma; Xingxiao Yang; Lianmei Zhao; Xuexiao Wang; Lihua Liu; Wenjing Jiao; Yuanyuan Wei; Baoen Shan
Journal:  Oncol Lett       Date:  2018-01-29       Impact factor: 2.967

8.  The Promises of Quantitative Proteomics in Precision Medicine.

Authors:  Bhagwat Prasad; Marc Vrana; Aanchal Mehrotra; Katherine Johnson; Deepak Kumar Bhatt
Journal:  J Pharm Sci       Date:  2016-12-08       Impact factor: 3.534

9.  Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.

Authors:  Yiying Huang; Md Tozammel Hoque; Mohammad-Ali Jenabian; Kishanda Vyboh; Sana-Kay Whyte; Nancy L Sheehan; Pierre Brassard; Maud Bélanger; Nicolas Chomont; Courtney V Fletcher; Jean-Pierre Routy; Reina Bendayan
Journal:  J Antimicrob Chemother       Date:  2016-04-13       Impact factor: 5.790

Review 10.  Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets.

Authors:  Marçal Pastor-Anglada; Sandra Pérez-Torras
Journal:  Front Pharmacol       Date:  2015-02-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.